Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
The International Journal of Neuropsychopharmacology|December 19, 2013
Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂Harumasa Takano, Ryosuke Arakawa, Tsuyoshi Nogami, et al.
The International Journal of Neuropsychopharmacology|October 17, 2012
Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2)Tsuyoshi Nogami, Harumasa Takano, Ryosuke Arakawa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2014
Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer ¹¹C-AZD2184Hiroshi Ito, Hitoshi Shimada, Hitoshi Shinotoh, et al.
Asian Journal of Psychiatry|February 28, 2026
Educational spillover effect within a cluster: Impact of guideline education for schizophrenia and major depressive disorder on psychiatrists' treatment behavior in a real-world multicenter studyToru Horinouchi, Yusuke Arai, Naomi Hasegawa, et al.
Molecular Psychiatry|December 16, 2024
Electroconvulsive therapy-specific volume changes in nuclei of the amygdala and their relationship to long-term anxiety improvement in depressionYuzuki Ishikawa, Naoya Oishi, Yusuke Kyuragi, et al.
BMC Psychiatry|October 9, 2025
Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical settingShun Igarashi, Takashi Tsuboi, Naomi Hasegawa, et al.
The International Journal of Neuropsychopharmacology|March 28, 2025
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide studyShinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, et al.
BMC Psychiatry|May 28, 2024
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter studyToshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
BMC Psychiatry|June 28, 2023
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
The International Journal of Neuropsychopharmacology|June 20, 2022
Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide StudyShinichiro Ochi, Hiromi Tagata, Naomi Hasegawa, et al.
Pageof 7